ADRX: Fisk Ryan discloses securities transactions

By AlphaYouPublished Sep 28, 2026Form 4

Stocks in this disclosure

Reported activity

Fisk Ryan

Reporting filer

Fisk Ryan reported Grant or award in ADARx Pharmaceuticals, Inc.: 170692 units of Employee Stock Option (right to buy) (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 28, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Employee Stock Option (right to buy) (derivative)	Fisk Ryan	2026-09-24	A	Grant or award	170692	0	170,692	4 days	Filed terms security Title: Employee Stock Option (right to buy) conversion Or Exercise Price: 17 transaction Date: 2026-09-24 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 170692 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-09-23 underlying Security Title: Common Stock underlying Security Shares: 170692 shares Owned Following Transaction: 170692 direct Or Indirect Ownership: D nature Of Ownership:

Employee Stock Option (right to buy) (derivative)

Owner: Fisk Ryan
Date: 2026-09-24
Code: A
Action: Grant or award
Quantity: 170692
Price: 0
Following holdings: 170,692
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Employee Stock Option (right to buy)
conversion Or Exercise Price: 17
transaction Date: 2026-09-24
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 170692
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-23
underlying Security Title: Common Stock
underlying Security Shares: 170692
shares Owned Following Transaction: 170692
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Fisk Ryan: CFO and CBO.
F1: 1/4th of the total shares vest and become exercisable on September 24, 2027 and the remaining shares vest and become exercisable in equal quarterly installments thereafter over a three-year period, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Employee Stock Option (right to buy) (derivative)

Fisk Ryan

2026-09-24

Grant or award

170692

170,692

4 days

Filed terms

security Title: Employee Stock Option (right to buy)
conversion Or Exercise Price: 17
transaction Date: 2026-09-24
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 170692
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-23
underlying Security Title: Common Stock
underlying Security Shares: 170692
shares Owned Following Transaction: 170692
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Fisk Ryan: CFO and CBO.

F1: 1/4th of the total shares vest and become exercisable on September 24, 2027 and the remaining shares vest and become exercisable in equal quarterly installments thereafter over a three-year period, subject to the Reporting Person's continued service to the Issuer on each vesting date.